
AmplifAI, the platform offering a fully integrated 360-degree view of enterprise contact center data and customer interactions, today announced it has raised $33.7 million in Series B funding and credit facility. This cutting-edge platform leverages generative AI-enabled actions to optimize both human and AI agent performance in real-time. The funding round was led by CVS Health Ventures, with participation from existing investors LiveOak Ventures and Dallas Venture Partners.
This investment will further accelerate AmplifAI’s mission to transform customer service operations and drive unparalleled performance improvements across the enterprise.
Read More – RefAssured Raises $3.3M in Seed Funding
With growing pressure on contact centers to reduce costs while strengthening customer loyalty, retention, and sales, AmplifAI is reimagining the contact center using an AI first approach. The platform ensures that human agents focus on complex, high value interactions while AI agents seamlessly manage routine contacts. By unifying both human and AI performance in one platform, AmplifAI transforms conversations and workflows across every level of the contact center, delivering efficiency, empathy, and measurable outcomes.
AmplifAI’s platform unifies customer surveys, voice recordings, chat, and chatbot conversations with metrics, behavioral data, contact reasons, and systemic product or process issues. By applying advanced analytics and AI to this multi-channel data, AmplifAI not only uncovers hidden customer pain points but also generates real-time coaching, workflows, and automated actions. This approach reduces friction, strengthens loyalty, and drives measurable business results.
Since its founding in 2018, AmplifAI has partnered with leading brands across retail, healthcare, financial services, and tech, delivering measurable impact, including: increasing sales conversion by over 100%, reducing cost per contact by nearly 10% and improving resolution rates by over 20%. AmplifAI was also recognized as a Cool Vendor by Gartner in 2024 and as a Leading Pioneer in the Automated QA/QM Prism by CMP Research.
Read More – Genstore Raises $10M in Seed Funding